Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromes
- PMID: 16918268
- DOI: 10.1586/14779072.4.4.503
Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromes
Abstract
The current epidemic of obesity warrants aggressive screening for associated comorbid conditions; namely, the metabolic syndrome and diabetes mellitus. Approximately 25-30% of patients with acute coronary syndrome have diabetes. Of the remaining patients, most have a spectrum of abnormal glucose metabolism, including previously undiagnosed impaired fasting glucose and diabetes mellitus. This article reviews the current literature and the author's own experience of this subject, as well as highlighting effective new agents in treating diabetes.
Similar articles
-
Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome.Am J Cardiol. 2005 Aug 1;96(3):363-5. doi: 10.1016/j.amjcard.2005.03.076. Am J Cardiol. 2005. PMID: 16054458
-
Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.Kardiol Pol. 2007 Oct;65(10):1181-6; discussion 1187-9. Kardiol Pol. 2007. PMID: 17979046 English, Polish.
-
Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.Metabolism. 2007 Oct;56(10):1396-401. doi: 10.1016/j.metabol.2007.05.011. Metabolism. 2007. PMID: 17884451 Clinical Trial.
-
Diabetic cardiomyopathy.Endocrinol Metab Clin North Am. 2006 Sep;35(3):575-99, ix. doi: 10.1016/j.ecl.2006.05.003. Endocrinol Metab Clin North Am. 2006. PMID: 16959587 Review.
-
Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.Endocrinol Metab Clin North Am. 2006 Sep;35(3):561-74, ix. doi: 10.1016/j.ecl.2006.06.001. Endocrinol Metab Clin North Am. 2006. PMID: 16959586 Review.
Cited by
-
Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.Diabetes Metab Res Rev. 2015 Sep;31(6):603-9. doi: 10.1002/dmrr.2646. Epub 2015 May 12. Diabetes Metab Res Rev. 2015. PMID: 25728823 Free PMC article.
-
Undiagnosed Impaired Glucose Tolerance and Type-2 Diabetes in Acute Myocardial Infarction Patients: Fequency, Characteristics and Long-Term Mortality.Front Cardiovasc Med. 2022 Apr 25;9:869395. doi: 10.3389/fcvm.2022.869395. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35548418 Free PMC article.
-
Impact of Admission Glucose on Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Meta-Analysis.Acta Cardiol Sin. 2016 Mar;32(2):194-204. doi: 10.6515/acs20150526a. Acta Cardiol Sin. 2016. PMID: 27122950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical